ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2194

Blue Digit Syndrome: The Rheumatologist’s Perspective

Helena Borrell1, Javier Narváez2, Eulalia Armengol1, Milagros Ricse1, Gloria Albert1, Sergi Heredia1, Andrea Zacarias1, Carmen Gomez Vaquero1 and Joan Miquel Nolla1, 1Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: systemic sclerosis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Blue or purple digit syndrome (or sign) is a cutaneous manifestation of multiple diseases that produce acute or subacute ischemic compromise in one or more fingers or toes. The most frequent cause of this syndrome is a reduction in arterial blood flow due to compromise or occlusion of small peripheral vessels, with preservation of the distal pulses.

The finger or toe affected by ischemia turns blue or violet and may develop necrosis. Whatever the cause, blue digit syndrome is a medical emergency requiring rapid diagnosis and specific treatment, given the risk of progression to irreversible necrosis. Only a very small percentage of cases need surgical intervention; the great majority of patients can be safely managed by medical therapy. Given their nature, medical cases should be managed by rheumatology services. Our aim was to evaluate the frequency, etiology and outcome in a series of patients admitted with blue digit syndrome in the Department of Rheumatology of the University Hospital of Bellvitge, a tertiary care teaching institution in Barcelona, Spain.

Methods: Ambispective cohort study of all patients admitted to our department with blue digit syndrome between 1990 and the first quarter of 2014.

Results: 41 patients (12 women and 19 men) were identified, with a mean age at diagnosis of 55 ± 18.8 years (range: 23-86 years). In 75% (31/41) of patients showed ischemic compromise of one or more fingers (being the second and third fingers most commonly affected), in 15% (6/41) were affected one or several fingers feet, and in 10% (4/41) remaining fingers and toes are affected simultaneously. The main etiologies are summarized in Table 1.

Number of   cases

Autoimmune diseases

Buerger’s disease

Crioglobulinemia related to Sjogren’s syndrome or HCV infection

Other primary systemic vasculitis or Vasculitis Associated with Systemic Disease (RA, SLE)

Systemic sclerosis (scleroderma)

Mixed connective tissue disease (MCTD)

11

3

7

           10           

1

Pseudovasculitis

Cholesterol crystal embolism

Antiphospholipid syndrome

Paraneoplastic acral vascular síndrome

Hypothenar hammer syndrome 

2

2

          2          

1

Myeloproliferative síndromes (essential thrombocythemia)

               1

Arteriosclerosis

               1

Sixty per cent of patients (24/41) also had cardiovascular risk factors, the most common being active smoking and high blood pressure. Three of the patients with Buerger’s disease were cannabis smokers.

Ninety per cent of patients (37/41) progressed well with conservative medical treatment and only 10% (4/41) required amputation (one case with arteriosclerosis and three patients with scleroderma).

Conclusion: In our experience, the most common causes of blue digit syndrome are systemic sclerosis and vasculitis. Differential diagnosis should also include pseudovasculitis, observed in a considerable percentage (17%) of these patients. Despite its severity, the ischemia usually responds to conservative medical treatment and amputation is unnecessary in most cases.


Disclosure:

H. Borrell,
None;

J. Narváez,
None;

E. Armengol,
None;

M. Ricse,
None;

G. Albert,
None;

S. Heredia,
None;

A. Zacarias,
None;

C. Gomez Vaquero,
None;

J. M. Nolla,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blue-digit-syndrome-the-rheumatologists-perspective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology